BBAS3:BMFBOVESPABanco do Brasil S.A. Analysis
Data as of 2026-06-12 - not real-time
ARS 2,920.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Banco do Brasil trades at 2,920, well below its 20‑day (3,021), 50‑day (3,258) and 200‑day (3,170) simple moving averages, signaling a bearish technical backdrop. The RSI of 41.7 reinforces modest downside momentum, while a bearish MACD (line below signal and a negative histogram) adds to the short‑term weakness. Volume is increasing, but the price sits only modestly above the identified support at 2,727.5, leaving limited upside before hitting the 3,350 resistance. On the valuation front, the stock’s price‑to‑book ratio of 0.32 is markedly low, suggesting it may be undervalued relative to its book value despite a zero PE and lack of dividend. Fundamentals show a 21.8% revenue decline, yet profit margins remain healthy at 20% and ROE sits near 9%, indicating operational resilience. High 30‑day volatility (≈48.6%) and a beta around 1.0 point to market‑aligned risk, while the Fear & Greed Index at “Extreme Greed” hints at elevated investor optimism that may be unwarranted given the mixed fundamentals.
In summary, the stock appears undervalued on a book basis but faces short‑term technical pressure, significant volatility, and macro‑regional risks; a cautious stance is warranted while monitoring for potential upside if earnings stabilize and revenue rebounds.
In summary, the stock appears undervalued on a book basis but faces short‑term technical pressure, significant volatility, and macro‑regional risks; a cautious stance is warranted while monitoring for potential upside if earnings stabilize and revenue rebounds.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Price below all major SMAs
- Bearish MACD and RSI below 50
- Proximity to support level with limited upside
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Improving profit margins despite revenue decline
- Low price‑to‑book offering value potential
- Elevated volatility and market sentiment uncertainty
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong book value relative to market price
- Resilient earnings profile and ROE around 9%
- Potential recovery in Brazilian credit market and earnings
Key Metrics & Analysis
Financial Health
Revenue Growth-21.80%
Profit Margin20.42%
ROE9.22%
ROA0.70%
P/B Ratio0.3
Op. Cash FlowARS54.2B
Industry P/E16.6
Technical Analysis
TrendNeutral
RSI41.7
SupportARS 2,727.50
ResistanceARS 3,350.00
MA 20ARS 3,021.00
MA 50ARS 3,257.10
MA 200ARS 3,169.90
MACDBearish
VolumeIncreasing
Fear & Greed Index86.71
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta1.02
Volatility48.64%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskHigh
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.